八戒体育

八戒体育

Products

Company Profile

SHANGHAI YINGRUI BIOPHARMA CO.,LTD

SHANGHAI YINGRUI BIOPHARMA CO.,LTD

Shanghai Yingrui Biopharma Co., Ltd. is a high-tech pharmaceutical and chemical product enterprise which specializes in R & D, production and sales of API and intermediates. The company has always been dedicated to R & D and production of antiviral and anti-tumor drugs, etc. The company is equipped with advanced production equipment and detection equipment...

Enterprise Display

News

Company Newsmore +

Fight against the Epidemic Together with You

八戒体育:2020-04-15

Supply Large Quantities of Oseltamivir Phosphate (CAS:

八戒体育:2020-04-15

Large Supply of Bromoacetone

八戒体育:2020-04-13

2020 YingRui year's meeting

八戒体育:2020-01-14

Lunar New Year Holiday Arrangement

八戒体育:2020-01-13

2019 CPHI China is successfully ended!

八戒体育:2019-06-25

Congratulations on the success of the new website of Yin

八戒体育:2019-06-25

Fight against the Epidemic Together

八戒体育:2020-04-15

Supply Large Quantities of Oseltami

八戒体育:2020-04-15

Large Supply of Bromoacetone

八戒体育:2020-04-13

2020 YingRui year's meeting

八戒体育:2020-01-14

Lunar New Year Holiday Arrangement

八戒体育:2020-01-13

2019 CPHI China is successfully ende

八戒体育:2019-06-25

Congratulations on the success of th

八戒体育:2019-06-25

Industry Newsmore +

The National Health Insurance Bureau responded that Pfiz

八戒体育:2023-01-12

Novo Nordisk Shanghai and Shanghai Pharmaceutical Holdin

八戒体育:2022-12-09

Review of clinical application of new drugs in the first

八戒体育:2022-11-28

Why are epidemic prevention and control measures adjuste

八戒体育:2022-11-14

China Center for Disease Control and prevention: the fiv

八戒体育:2022-09-19

The global pharmaceutical industry chain is reshaping, a

八戒体育:2022-08-16

Although China's generic drugs started late, the future

八戒体育:2022-08-05

Good API industry attracts investors' attention

八戒体育:2021-03-19

The National Health Insurance Bureau

八戒体育:2023-01-12

Novo Nordisk Shanghai and Shanghai P

八戒体育:2022-12-09

Review of clinical application of ne

八戒体育:2022-11-28

Why are epidemic prevention and cont

八戒体育:2022-11-14

China Center for Disease Control and

八戒体育:2022-09-19

The global pharmaceutical industry c

八戒体育:2022-08-16

Although China's generic drugs star

八戒体育:2022-08-05

Good API industry attracts investors

八戒体育:2021-03-19

Home | About Us | News | Products | 八戒体育:Technology Transfer | Job | Inquiry | 八戒体育:Contact Us

Home | About us | News | Products
八戒体育:Technology Transfer | Job | Inquiry | 八戒体育:Contact Us

Copyright © 2017-2020 SHANGHAI YINGRUI BIOPHARMA CO.,LTD 沪ICP备11038445号-1
TEL：+86-21-33585366(DDT)、34666753 FAX：+86-21-34979012
E-mail：info@bayareasuccessbusinesscoach.com ADD：1885 Metropolitan Road, Minhang District, Shanghai Code：201108